Published in Mol Endocrinol on April 01, 1993
Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J (1994) 2.62
PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol (2001) 1.85
Spatiotemporal expression patterns of chicken ovalbumin upstream promoter-transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon. Proc Natl Acad Sci U S A (1994) 1.54
A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol (1995) 1.21
Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J (1997) 1.19
Ligand-dependent and -independent transactivation by thyroid hormone receptor beta 2 is determined by the structure of the hormone response element. Mol Cell Biol (1995) 0.94
Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR beta 4-like transgene. EMBO J (1994) 0.92
Adenovirus E1A functions as a cofactor for retinoic acid receptor beta (RAR beta) through direct interaction with RAR beta. Mol Cell Biol (1995) 0.91
Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol Cell Biol (1995) 0.89
Characterization of the AB (AF-1) region in the muscle-specific retinoid X receptor-gamma: evidence that the AF-1 region functions in a cell-specific manner. Nucleic Acids Res (1996) 0.85
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature (1983) 3.47
Intercellular adhesion molecule-1. J Mol Med (Berl) (1996) 2.94
Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. J Biol Chem (1996) 1.60
The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification. Nature (1993) 1.54
Sodium/proton exchange in mouse neuroblastoma cells. J Biol Chem (1981) 1.51
Ionic responses and growth stimulation induced by nerve growth factor and epidermal growth factor in rat pheochromocytoma (PC12) cells. J Cell Biol (1983) 1.51
Rapid ionic events and the initiation of growth in serum-stimulated neuroblastoma cells. Cell (1981) 1.44
Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci (1999) 1.42
Microviscosity modulation during the cell cycle of neuroblastoma cells. Proc Natl Acad Sci U S A (1977) 1.26
Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ (1995) 1.23
A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol (1998) 1.20
Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Cell Growth Differ (1998) 1.16
Lateral diffusion of membrane lipids and proteins is increased specifically in neurites of differentiating neuroblastoma cells. Biochim Biophys Acta (1979) 1.15
Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies. EMBO J (1986) 1.15
The cell cycle, cell death, and cell morphology during retinoic acid-induced differentiation of embryonal carcinoma cells. Dev Biol (1984) 1.15
Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mech Dev (1999) 1.13
The distribution of endogenous retinoic acid in the chick embryo: implications for developmental mechanisms. Development (1998) 1.11
Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol (1993) 1.10
Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J Biol Chem (1999) 1.09
Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem (1997) 1.07
Ectopic expression of c-jun leads to differentiation of P19 embryonal carcinoma cells. EMBO J (1990) 1.06
Neuroblastoma cells produce transforming growth factors during exponential growth in a defined hormone-free medium. Proc Natl Acad Sci U S A (1984) 1.05
Lateral diffusion of membrane lipids and proteins during the cell cycle of neuroblastoma cells. Proc Natl Acad Sci U S A (1980) 1.04
Aggregation and cell cycle dependent retinoic acid receptor mRNA expression in P19 embryonal carcinoma cells. Mech Dev (1992) 1.01
A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation. Nucleic Acids Res (1992) 1.01
Clonal variants of differentiated P19 embryonal carcinoma cells exhibit epidermal growth factor receptor kinase activity. Dev Biol (1985) 1.01
Ontogeny of estrogen receptor-beta expression in rat testis. Endocrinology (1999) 1.00
Epidermal growth factor receptor expression during morphological differentiation of pheochromocytoma cells, induced by nerve growth factor or dibutyryl cyclic AMP. J Cell Physiol (1987) 0.98
Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines. Mol Carcinog (1993) 0.98
Neuroblastoma cells express c-sis and produce a transforming growth factor antigenically related to the platelet-derived growth factor. Mol Cell Biol (1985) 0.98
The gene for the ligand binding chain of the human interferon gamma receptor. Immunogenetics (1997) 0.97
Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem (1997) 0.97
The plasma membrane as a regulatory site in growth and differentiation of neuroblastoma cells. Int Rev Cytol (1982) 0.97
Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells. J Biol Chem (1997) 0.96
Retinoic acid hydroxylase (CYP26) is a key enzyme in neuronal differentiation of embryonal carcinoma cells. Dev Biol (1999) 0.96
Cell scattering of SK-N-MC neuroepithelioma cells in response to Ret and FGF receptor tyrosine kinase activation is correlated with sustained ERK2 activation. Oncogene (1997) 0.94
Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor beta2 promoter. J Biol Chem (1998) 0.93
Mouse and human retinoic acid receptor beta 2 promoters: sequence comparison and localization of retinoic acid responsiveness. DNA Seq (1991) 0.92
Cross-talk between steroids and NF-kappa B: what language? Trends Biochem Sci (1998) 0.92
Serum triggers a sequence of rapid ionic conductance changes in quiescent neuroblastoma cells. Nature (1979) 0.92
Two receptor classes for epidermal growth factor on pheochromocytoma cells, distinguishable by temperature, lectins, and tumor promoters. J Cell Physiol (1985) 0.92
Protein kinase C and phorbol ester receptor expression related to growth and differentiation of nullipotent and pluripotent embryonal carcinoma cells. Dev Biol (1986) 0.91
Expression of retinoic acid 4-hydroxylase (CYP26) during mouse and Xenopus laevis embryogenesis. Mech Dev (1999) 0.91
Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol Endocrinol (2001) 0.91
Adenovirus E1A functions as a cofactor for retinoic acid receptor beta (RAR beta) through direct interaction with RAR beta. Mol Cell Biol (1995) 0.91
Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor. J Cell Physiol (1985) 0.90
Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. J Mol Endocrinol (2004) 0.90
All-trans-4-oxo-retinoic acid: a potent inducer of in vivo proliferation of growth-arrested A spermatogonia in the vitamin A-deficient mouse testis. Endocrinology (1996) 0.90
Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol (1995) 0.89
Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol (1994) 0.89
Differentiation-dependent expression of provirus-activated int-1 oncogene in clonal cell lines derived from a mouse mammary tumor. Oncogene (1990) 0.88
Differential regulation of AP1 activity by retinoic acid in hormone-dependent and -independent breast cancer cells. Mol Cell Endocrinol (1995) 0.88
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. Br J Cancer (2002) 0.88
Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol (1993) 0.87
Modulations of Na+ transport during the cell cycle of neuroblastoma cells. J Cell Physiol (1982) 0.87
Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the developing hindbrain. Development (1998) 0.87
Family tree analysis of a transformed cell line and the transition probability model for the cell cycle. Exp Cell Res (1981) 0.87
Embryonic stem cells stably transfected with mRAR beta 2-lacZ exhibit specific expression in chimeric embryos. Int J Dev Biol (1992) 0.87
Nuclear factor-kappa-B/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol Hum Reprod (1996) 0.86
Identification of target cells for the genomic effects of estrogens in bone. Endocrinology (2007) 0.86
Millisecond to microsecond time scale dynamics of the retinoid X and retinoic acid receptor DNA-binding domains and dimeric complex formation. Biochemistry (1999) 0.85
Transcriptional regulation of retinoic acid receptor beta in retinoic acid-sensitive and -resistant P19 embryocarcinoma cells. Mech Dev (1991) 0.84
NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology (1997) 0.84
The effect of 9-cis-retinoic acid on proliferation and differentiation of a spermatogonia and retinoid receptor gene expression in the vitamin A-deficient mouse testis. Endocrinology (1998) 0.83
Metabolism of retinoic acid: implications for development and cancer. Int J Vitam Nutr Res (1998) 0.83
The solution structure of the human retinoic acid receptor-beta DNA-binding domain. J Biomol NMR (1993) 0.83
Quantitative analysis of modulations in numerical and lateral distribution of intramembrane particles during the cell cycle of neuroblastoma cells. J Cell Biol (1983) 0.83
Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids. Exp Cell Res (1999) 0.82
Nuclear factor-kappa B repression in antiinflammation and immunosuppression by glucocorticoids. Trends Endocrinol Metab (2008) 0.82
Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms. J Biol Chem (1998) 0.82
Differential expression pattern of retinoid X receptors in adult murine testicular cells implies varying roles for these receptors in spermatogenesis. Biol Reprod (1998) 0.82
Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines. Br J Cancer (1997) 0.82
Loss of EGF binding and cation transport response during differentiation of mouse neuroblastoma cells. J Cell Biochem (1983) 0.82
Changes in retinoic acid receptor messenger ribonucleic acid levels in the vitamin A-deficient rat testis after administration of retinoids. Endocrinology (1992) 0.81
Homo- and heteronuclear NMR studies of the human retinoic acid receptor beta DNA-binding domain: sequential assignments and identification of secondary structure elements. Biochemistry (1992) 0.81
A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro. Teratology (1984) 0.81
Screening for cytotoxicity in neuroblastoma cells. I. Dependence of growth inhibition on the presence of serum. Toxicol Lett (1983) 0.81
Phospholipase A2 inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappaB activation. Cytokine (1999) 0.81
Monovalent cation transport during the cell cycle (review). Anticancer Res (1983) 0.81
Detection of oestrogenic activity of steroids present during mammalian gestation using oestrogen receptor alpha- and oestrogen receptor beta-specific in vitro assays. J Endocrinol (2002) 0.80
Ultrastructural aspects of rapid plasma membrane growth in mitotic neuroblastoma cells. Eur J Cell Biol (1983) 0.80
CYP2C7 expression in rat liver and hepatocytes: regulation by retinoids. Mol Cell Endocrinol (1997) 0.80
The role of TGF-beta production in growth inhibition of breast-tumor cells by progestins. Int J Cancer (1995) 0.80
Metabolism to a response pathway selective retinoid ligand during axial pattern formation. Proc Natl Acad Sci U S A (1998) 0.80
Activation function 1 of retinoic acid receptor beta 2 is an acidic activator resembling VP16. J Biol Chem (1995) 0.80
Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity. Am J Pathol (1996) 0.79
Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RAR alpha. Differentiation (1992) 0.79
E1A functions as a coactivator of retinoic acid-dependent retinoic acid receptor-beta 2 promoter activation. Mol Endocrinol (1993) 0.79
A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum. Clin Endocrinol (Oxf) (2003) 0.79
Cation transport and growth control in neuroblastoma cells in culture. Prog Clin Biol Res (1982) 0.79
Dominant negative retinoic acid receptor beta. Mech Dev (1993) 0.79
Rapid effects of nerve growth factor on the Na+, K+-pump in rat pheochromocytoma cells. Exp Cell Res (1981) 0.79
Cytokine signal transduction in P19 embryonal carcinoma cells: regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling. Exp Cell Res (1999) 0.78
Genomic organization of the human retinoic acid receptor beta 2. Biochem Biophys Res Commun (1992) 0.78
Morphogenetic action of retinoids and estrogens. Int J Dev Biol (1999) 0.78